Skip to search formSkip to main contentSkip to account menu

Carbonic Anhydrase IX

Known as: CAIX Protein, Carbonic Anhydrase 9, Carbonic Anhydrase IX [Chemical/Ingredient] 
A carbonic anhydrase and transmembrane protein that consists of an N-terminal PROTEOGLYCAN-like domain, a catalytic region, a single-pass… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Among the players of the adaptive response of cancer cells able to promote a resistant and aggressive phenotype, carbonic… 
2016
2016
PURPOSE: Tumor hypoxia is a well-recognized driver of resistance to traditional cancer therapies such as chemotherapy and… 
2013
2013
Ductal carcinoma in situ (DCIS) of the breast is difficult to remove completely during surgery as it is not palpable and can… 
2012
2012
Purpose: Bevacizumab, an anti-VEGFA antibody, inhibits the developing vasculature of tumors, but resistance is common… 
2012
2012
Carbonic anhydrase IX (CAIX) is a hypoxia and HIF-1 inducible protein that regulates intra- and extracellular pH under hypoxic… 
2011
2011
Purpose:Carbonic anhydrase IX (CAIX) is ahypoxia-inducible enzyme,which is associatedwith neoplastic growth. Ectopic CA IX… 
2011
2011
Proceedings: AACR 102nd Annual Meeting 2011‐‐ Apr 2‐6, 2011; Orlando, FL Carbonic anhydrase IX (CAIX) is a membrane-bound, tumor… 
2009
2009
Carbonic anhydrase IX (CA IX) is a transmembrane glycoprotein highly expressed in clear cell carcinoma of the kidney and in a… 
2006
2006
Purpose: Hypoxia in breast cancer is associated with poor prognosis and down-regulation of the estrogen receptor. Carbonic…